Susan Hubl concentrates her practice on US and foreign patent prosecution in life science technologies including molecular biology tools and methods, personalized medicine and molecular diagnostics, and pharmaceuticals including RNA silencing. Her practice also includes intellectual property counseling, due diligence and litigation support where she has done work in the fields of biofuels, vaccines, PCR reagents, transgenic animals, fertility therapeutics, medical devices, and microarrays. Her clients include biotechnology companies, startups, venture capitalists, and universities.
Susan has worked as a patent agent and legal technical analyst since 1997. While a graduate student at UC Berkeley, she performed a structure-function mutational analysis of yeast heat shock transcription factor (HSF) in the laboratory of Dr. Hilary Nelson. Before graduate school she worked as a research associate at The Gladstone Institute of Cardiovascular Disease in the laboratory of Dr. Steve Young studying lipoprotein mutations and their role in cardiovascular disease. She was an author on 11 scientific papers in peer reviewed journals.